Vishnu Chemicals Limited reported a consolidated net profit of ₹39.6 crore for the first quarter ended June 30, 2026, marking a 23% increase from ₹32.2 crore in the corresponding period of FY26. The Hyderabad-based specialty chemicals manufacturer saw its consolidated revenue from operations rise 24.9% year-on-year to ₹433.4 crore, driven primarily by robust demand in international markets where sales surged 52%. This growth trajectory underscores the company’s expanding footprint in global specialty chemical segments, despite a planned maintenance shutdown at its Vizag facility that moderated sequential performance.

The Board of Directors approved the unaudited financial results on August 01, 2026, following a limited review by statutory auditors Jampani & Associates. Consolidated income from operations stood at ₹433.4 crore, compared to ₹346.9 crore in the prior-year quarter. Overseas sales contributed significantly, rising to ₹239.4 crore from ₹157.4 crore, while domestic revenue grew modestly to ₹192.7 crore. Total expenses increased largely due to higher manufacturing and selling costs. Profit before tax rose 32% to ₹55.1 crore. The company’s basic and diluted earnings per share (EPS) were ₹5.89, up from ₹4.79 in Q1FY26.

Consolidated Financial Performance

On a standalone basis, Vishnu Chemicals reported a net profit of ₹31.9 crore, a significant jump of 77% from ₹18.0 crore in the corresponding quarter of FY26. Standalone revenue from operations grew 13% to ₹297.7 crore. Overseas sales for the standalone entity increased 33% to ₹161.1 crore, while domestic sales remained relatively flat at ₹135.7 crore. Standalone EPS rose to ₹4.73 from ₹2.67.

What the Numbers Show

The divergence between consolidated and standalone performance highlights the contribution of subsidiaries to overall profitability. While standalone revenue growth was moderate at 13%, consolidated revenue expanded by nearly 25%, indicating that subsidiaries are driving top-line momentum. Furthermore, the 52% surge in consolidated overseas sales versus a negligible rise in domestic sales suggests a strategic shift or stronger demand in export markets. This geographic mix improvement is a key driver behind the margin expansion and profit growth observed in the quarter. Other income stood at ₹12.8 crore during the quarter, primarily due to net foreign exchange gains resulting from higher exports.

Strategic Initiatives and Outlook

Management highlighted several operational developments supporting medium-term growth. In the Chromium segment, margins improved due to a strategic shift towards higher-value-added derivatives over base specialty chemicals. Barium operations remained stable with optimum capacity utilization, and expansion of Ramadas operations leveraging specialized US technology is in process to enhance backward integration. Strontium revenues in Q1FY27 were nearly equal to full-year annual revenues achieved in FY26, reflecting encouraging scale-up.

The company’s South Africa business is progressing towards operations, with infrastructure refurbishment and regulatory compliances underway; operations are expected to commence from H2FY27. Additionally, Vishnu Chemicals plans to add approximately 20 MW of solar power capacity across its Vizag and Srikalahasti operations, expanding its existing renewable energy portfolio of 4.3 MW to reduce electricity costs. However, the company noted that ocean freight costs have increased amid geopolitical tensions in West Asia, with rates from India to Latin America rising from approximately USD3,000–4,000 to around USD9,000 over the past three months.

The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Jampani & Associates issued an unmodified opinion on both standalone and consolidated statements. Notably, the auditors did not review the interim financial information of one Indian subsidiary and one step-down subsidiary, whose results reflect total revenue of ₹40.48 crore and a net loss of ₹4.20 crore for the quarter, relying instead on reports from other auditors.

Vishnu Chemicals Limited will host an analyst and institutional investor meeting on August 12, 2026, as part of the Emkay Confluence 2026 event in Mumbai. The company disclosed the schedule pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing shareholders and market participants of its engagement plans with financial intermediaries.

The meeting is scheduled to take place physically at the Emkay Confluence venue in Mumbai from 12:00 PM to 6:00 PM. Management intends to conduct both one-on-one discussions and group meetings with attending analysts and institutional investors. This engagement allows the company to communicate its operational updates and strategic outlook directly to key stakeholders.

The disclosure was submitted to BSE Limited and the National Stock Exchange of India Limited on July 29, 2026. Vibha Shinde, Company Secretary and Compliance Officer, signed the intimation, confirming adherence to regulatory norms for timely disclosure of such events.

Vishnu Chemicals Limited explicitly stated that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during the investor meeting. This assurance aligns with standard compliance practices to ensure fair information dissemination across all market participants. The company noted that changes to the schedule may occur due to exigencies from either party.

Engagement Details

The Emkay Confluence is a significant platform for corporate-investor interaction in India. By participating in this event, Vishnu Chemicals aims to maintain transparency and provide clarity on its business performance to the investment community. The format allows for detailed queries from analysts, facilitating a deeper understanding of the company’s financial health and future prospects among institutional holders.